Overview

Our Infectious Disease team provides world class services to accelerate your drug discovery process from target validation to PCC nomination.

The outstanding infrastructure and instrumentation allow us to conduct high quality researches both in vitro and in vivo for our clients.

• BSL-2 facilities (>3,500 ft²), antiviral & antibacterial
• ABSL-2 facilities (~3,000 ft², 6 animal rooms, holding capacity of 5,000 rodents, ALAAAC accredited), antiviral & antibacterial
• State-of-art instrumentation (e.g. COBAS system, POD810, Luminex, FACS, etc.)

Learn More about Infectious Disease

• Antiviral Services
• Virology Assays Supporting Human Clinical Trials
• HBV Platform
• HBV & HCV Molecular Testing Lab

Business Contact： 

• North America: Declan Ryan,  declan.ryan@wuxiapptec.com
• Europe and Israel: Dave Madge,  dave_madge@wuxiapptec.com
• China: Marcher Xu,  xu_longji@wuxiapptec.com
• Japan: Yan Zhu,  yan_zhu@wuxiapptec.com
• Korea: Suk Young Cho,  sycho@wuxiapptec.com